These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

341 related articles for article (PubMed ID: 20044626)

  • 21. Dual role of CCL3/CCR1 in oral squamous cell carcinoma: implications in tumor metastasis and local host defense.
    Silva TA; Ribeiro FL; Oliveira-Neto HH; Watanabe S; Alencar Rde C; Fukada SY; Cunha FQ; Leles CR; Mendonça EF; Batista AC
    Oncol Rep; 2007 Nov; 18(5):1107-13. PubMed ID: 17914560
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fos-related activator-1 is overexpressed in oral squamous cell carcinoma and associated with tumor lymph node metastasis.
    Zhang L; Pan HY; Zhong LP; Wei KJ; Yang X; Li J; Shen GF; Zhang Z
    J Oral Pathol Med; 2010 Jul; 39(6):470-6. PubMed ID: 20149058
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Restricted-expressed proliferation-associated protein (Repp86) expression in squamous cell carcinoma of the oral cavity.
    Fenner M; Wehrhan F; Jehle M; Amann K; Radespiel-Tröger M; Grabenbauer G; Zenk J; Nkenke E; Schinhammer M; Schultze-Mosgau S
    Strahlenther Onkol; 2005 Dec; 181(12):755-61. PubMed ID: 16362784
    [TBL] [Abstract][Full Text] [Related]  

  • 24. NY-ESO-1 protein expression and humoral immune responses in prostate cancer.
    Fosså A; Berner A; Fosså SD; Hernes E; Gaudernack G; Smeland EB
    Prostate; 2004 Jun; 59(4):440-7. PubMed ID: 15065093
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Expression of MMP1 mRNA in oral squamous cell carcinoma and paired normal tissues].
    Lü XZ; Zou YG; Yin XM; Chen WT; Zhang CP
    Nan Fang Yi Ke Da Xue Xue Bao; 2008 Aug; 28(8):1362-4. PubMed ID: 18753061
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MICA and MICB overexpression in oral squamous cell carcinoma.
    Liu CJ; Lui MT; Chen HL; Lin SC; Chang KW
    J Oral Pathol Med; 2007 Jan; 36(1):43-7. PubMed ID: 17181741
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Detection of survivin and p53 in human oral cancer: correlation with clinicopathologic findings.
    Khan Z; Tiwari RP; Mulherkar R; Sah NK; Prasad GB; Shrivastava BR; Bisen PS
    Head Neck; 2009 Aug; 31(8):1039-48. PubMed ID: 19340865
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Frequency of NY-ESO-1 and LAGE-1 expression in bladder cancer and evidence of a new NY-ESO-1 T-cell epitope in a patient with bladder cancer.
    Sharma P; Gnjatic S; Jungbluth AA; Williamson B; Herr H; Stockert E; Dalbagni G; Donat SM; Reuter VE; Santiago D; Chen YT; Bajorin DF; Old LJ
    Cancer Immun; 2003 Dec; 3():19. PubMed ID: 14680360
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antigen-specific immunity in neuroblastoma patients: antibody and T-cell recognition of NY-ESO-1 tumor antigen.
    Rodolfo M; Luksch R; Stockert E; Chen YT; Collini P; Ranzani T; Lombardo C; Dalerba P; Rivoltini L; Arienti F; Fossati-Bellani F; Old LJ; Parmiani G; Castelli C
    Cancer Res; 2003 Oct; 63(20):6948-55. PubMed ID: 14583496
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Increased Cyfra 21-1 concentration in saliva from primary oral squamous cell carcinoma patients.
    Zhong LP; Zhang CP; Zheng JW; Li J; Chen WT; Zhang ZY
    Arch Oral Biol; 2007 Nov; 52(11):1079-87. PubMed ID: 17612501
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression of human telomerase reverse transcriptase (hTERT) protein is significantly associated with the progression, recurrence and prognosis of oral squamous cell carcinoma in Taiwan.
    Chen HH; Yu CH; Wang JT; Liu BY; Wang YP; Sun A; Tsai TC; Chiang CP
    Oral Oncol; 2007 Feb; 43(2):122-9. PubMed ID: 16798059
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression of RCAS1 is significantly associated with the progression and prognosis of oral squamous cell carcinomas in Taiwan.
    Tsai TC; Yu CH; Cheng SJ; Liu BY; Chen HM; Chiang CP
    Oral Oncol; 2008 Aug; 44(8):759-66. PubMed ID: 18061525
    [TBL] [Abstract][Full Text] [Related]  

  • 33. survivin messenger RNA expression is a good prognostic biomarker for oesophageal carcinoma.
    Ikeguchi M; Kaibara N
    Br J Cancer; 2002 Oct; 87(8):883-7. PubMed ID: 12373603
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Expression of osteopontin mRNA in oral squamous cell carcinoma and normal oral mucosa].
    Lu XZ; Yin XM; Feng YY; Duan LQ; Chen WT; Zhang CP
    Nan Fang Yi Ke Da Xue Xue Bao; 2008 Jul; 28(7):1165-7. PubMed ID: 18676253
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunohistochemical expression of tumor antigens MAGE-A1, MAGE-A3/4, and NY-ESO-1 in squamous cell carcinoma of the penis.
    Hudolin T; Juretic A; Pasini J; Tomas D; Spagnoli GC; Heberer M; Dimanovski J; Kruslin B
    Urology; 2006 Jul; 68(1):205-7. PubMed ID: 16806422
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression of lysyl oxidase is correlated with lymph node metastasis and poor prognosis in esophageal squamous cell carcinoma.
    Sakai M; Kato H; Sano A; Tanaka N; Inose T; Kimura H; Sohda M; Nakajima M; Kuwano H
    Ann Surg Oncol; 2009 Sep; 16(9):2494-501. PubMed ID: 19526206
    [TBL] [Abstract][Full Text] [Related]  

  • 37. NY-ESO-1 expression and its serum immunoreactivity in esophageal cancer.
    Akcakanat A; Kanda T; Koyama Y; Watanabe M; Kimura E; Yoshida Y; Komukai S; Nakagawa S; Odani S; Fujii H; Hatakeyama K
    Cancer Chemother Pharmacol; 2004 Jul; 54(1):95-100. PubMed ID: 15118836
    [TBL] [Abstract][Full Text] [Related]  

  • 38. NY-ESO-1 and CTp11 expression may correlate with stage of progression in melanoma.
    Goydos JS; Patel M; Shih W
    J Surg Res; 2001 Jun; 98(2):76-80. PubMed ID: 11397121
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Expression of NY-ESO-1/LAGE-1 genes in hepatocellular carcinoma and autologous humoral responses induced thereby].
    Xing BC; Yuan YH; Hu ZG; Liu YX; Han Y; Liu N; Chen WF; Wang Y
    Zhonghua Yi Xue Za Zhi; 2004 Dec; 84(23):1980-2. PubMed ID: 15730810
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expression and clinical relevance of NY-ESO-1, MAGE-1 and MAGE-3 in neuroblastoma.
    Söling A; Schurr P; Berthold F
    Anticancer Res; 1999; 19(3B):2205-9. PubMed ID: 10472332
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.